Literature DB >> 11808878

Effect of meconium on the rate of in vitro subtype conversion of swine pulmonary surfactant.

Ryota Kakinuma1, Hiroshi Shimizu, Yunosuke Ogawa.   

Abstract

UNLABELLED: The interactions between pulmonary surfactant and meconium have been previously reported, however, no prior study has paid attention to the effect of meconium on the extracellular surfactant metabolism. We studied the effect of meconium on the rate of surfactant subtype conversion from surface-active large surfactant aggregates to inactive small surfactant aggregates using the in vitro surface area cycling method. Human meconium was added to a suspension of large surfactant aggregates isolated from swine lung lavage fluid and the mixture was cycled in a capped polystyrene tube at 37 degrees C. The conversion rate from large to small surfactant aggregates was dependent upon the amount of meconium added. By sufficiently increasing the surfactant concentration, meconium could not significantly affect the surfactant subtype conversion. The conversion rate was temperature-dependent and was slower at 4 degrees C. Heat treatment of meconium diminished the rate of conversion. The potent effect of meconium on surfactant subtype conversion appears to be related to an enzymatic protein containing a serine active site, since the conversion occurred at 37 degrees C and not at lower temperatures and the conversion was blocked in the presence of diisopropyl fluorophosphate.
CONCLUSION: Our study suggests that meconium can accelerate surfactant subtype conversion. We believe that the increased rate of conversion caused by meconium is a new mechanism for surfactant inactivation that could occur with lung injuries associated with meconium aspiration syndrome.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11808878     DOI: 10.1007/s00431-001-0858-8

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  5 in total

1.  Synthetic and natural surfactant differentially modulate inflammation after meconium aspiration.

Authors:  Anne Hilgendorff; Daniel Rawer; Martin Doerner; Erol Tutdibi; Michael Ebsen; Reinhold Schmidt; Andreas Guenther; Ludwig Gortner; Irwin Reiss
Journal:  Intensive Care Med       Date:  2003-09-03       Impact factor: 17.440

2.  Bronchoalveolar lavage with pulmonary surfactant/dextran mixture improves meconium clearance and lung functions in experimental meconium aspiration syndrome.

Authors:  Andrea Calkovska; Daniela Mokra; Anna Drgova; Ivan Zila; Kamil Javorka
Journal:  Eur J Pediatr       Date:  2007-10-19       Impact factor: 3.183

Review 3.  Glucocorticoids in the treatment of neonatal meconium aspiration syndrome.

Authors:  Daniela Mokra; Juraj Mokry
Journal:  Eur J Pediatr       Date:  2011-04-06       Impact factor: 3.183

4.  Morphological alterations of exogenous surfactant inhibited by meconium can be prevented by dextran.

Authors:  Matthias Ochs; Markus Schüttler; Guido Stichtenoth; Egbert Herting
Journal:  Respir Res       Date:  2006-06-06

5.  The effect of titanium dioxide nanoparticles on pulmonary surfactant function and ultrastructure.

Authors:  Carsten Schleh; Christian Mühlfeld; Karin Pulskamp; Andreas Schmiedl; Matthias Nassimi; Hans D Lauenstein; Armin Braun; Norbert Krug; Veit J Erpenbeck; Jens M Hohlfeld
Journal:  Respir Res       Date:  2009-09-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.